Bavarian Nordic A/S COPENHAGEN, Denmark, July 1, 2024 – Bavarian Nordic today announced the conversion of its existing undrawn DKK 1 billion syndicated revolving credit facility (RCF) into a sustainability-linked loan (SLL). The RCF agreement, entered with Danske Bank and Nordea in October 2023, has a three-year tenor with two one-year extension options and provides additional financial flexibility, e.g., to absorb fluctuations in working capital or to fulfil periodic significant milestone payments related to previous acquisitions. As planned, and in agreement with the lenders, the facility has now been linked to key performance indicators pertaining to Bavarian Nordic’s sustainability strategy. Hence, the interest rate margin will be adjusted contingent upon the successful achievement of predefined key performance indicators within the following areas, subject to annual assessment by an independent third party: Access to Medicine: Develop and execute on strategy with the purpose of expanding access to Bavarian Nordic’s vaccines in low- and middle-income countries. Responsible Supply Program: Increase share of key suppliers that have undergone qualified third-party audit on environmental, social and governance (ESG) parameters. Greenhouse Gas Emissions: Reduce annual Scope 1 and 2 greenhouse gas (GHG) emissions compared to 2023 baseline. "In recent years, we have significantly expanded our impact on public health through supply of life-saving vaccines, while also increasing our commitment towards our growing workforce, external stakeholders, and society at large. Sustainability is today an integral part of our strategy and business practices, and we are therefore pleased to incorporate sustainability targets into our financial commitments, encompassing both our efforts to support the green transition and our commitment to improving health across the globe. This represents an important step in our continuous work to integrate our sustainability ambitions across all operations," said Henrik Juuel, Executive Vice President and Chief Financial Officer of Bavarian Nordic. Nordea has acted as Coordinator and Documentation Agent and Danske Bank as Facility Agent and Sustainability Coordinator. About Bavarian Nordic Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com. Contacts Rolf Sass Sørensen, Vice President Investor Relations, [email protected], Tel: +45 61 77 47 43 Attachment 2024-07-01-en
Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...